News

Press Releases

Mar 24, 2014

Inflection Biosciences Announces Poster Presentation at the 2014 AACR Annual Meeting

Dublin, Ireland, March 24, 2014 Inflection Biosciences Ltd, a private company focused on the development of targeted small molecule...

Oct 17, 2013

Inflection Biosciences Announces Poster Presentation at the 2013 AACR-NCI-EORTC Conference

Dublin, Ireland, October 17, 2013 Inflection Biosciences Ltd, a private company focused on the development of targeted small molecule...

Aug 16, 2013

Dr Michael O’Neill, Inflection Biosciences' Director of R&D interviewed by Pharma Television

Dublin, Ireland, 16 August 2013 Inflection Biosciences Ltd, a private company focused on the development of targeted small molecule...

Jun 4, 2013

Inflection Licenses Preclinical Oncology Programs from the Spanish National Cancer Research Centre

Dublin, Ireland, June 4, 2013 Inflection Biosciences Ltd, a private company focused on the development of targeted small molecule...

Nov 21, 2012

Inflection Biosciences Selected to Present at International Investor Forum

Dublin, Ireland, November 21, 2012 Inflection Biosciences limited was selected as one of 25 Irish companies to present at the 5th...

Nov 6, 2012

Inflection Biosciences to attend 24th Annual EORTC-NCI-AACR Symposium

Dublin, Ireland, November 6, 2012 Inflection Biosciences to attend the the 24th Annual EORTC-NCI-AACR Symposium on Molecular Targets and...